Tirzepatide and the prevention of heart failure in obesity: a multi-center cohort study using the TriNetX database
Tirzepatide may reduce the risk of developing HF and improve cardiovascular outcomes in obese individuals. These findings highlight its potential role in HF prevention and warrant further prospective studies.
Authors
- Tsung Yu (ORCID: https://orcid.org/0000-0002-5773-3665)
- Chia‐Li Kao
- Kuan‐Jui Tseng
- Jheng‐Yan Wu (ORCID: https://orcid.org/0000-0002-3290-1909)
- Kuo-Chuan Hung (ORCID: https://orcid.org/0000-0002-4507-8085)
- Yu‐Min Lin (ORCID: https://orcid.org/0009-0005-1723-828X)
Institutions
- Chi Mei Medical Center (TW)
- National Cheng Kung University (TW)
- I-Shou University (TW)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1093/eurjpc/zwaf663
- Citations
- 2
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.78